{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:57:40Z","timestamp":1757624260674,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006671","name":"Maryland Department of Health","doi-asserted-by":"publisher","award":["6NU17CE924961"],"award-info":[{"award-number":["6NU17CE924961"]}],"id":[{"id":"10.13039\/100006671","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.dadr.2022.100111","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T22:59:15Z","timestamp":1667084355000},"page":"100111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Unsolicited reporting notifications (URNs) through Maryland's prescription drug monitoring program (PDMP): Characteristics of providers"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3888-3254","authenticated-orcid":false,"given":"Masoumeh","family":"Amin-Esmaeili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Gribble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renee M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel H","family":"Alinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Oyedele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Parnham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Himani","family":"Byregowda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin E.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Nyeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoko","family":"Susukida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2022.100111_bib0001","unstructured":"American Association of Colleges of Nursing, 2016. At White House event, AACN announces commitments by Nursing Schools to combat opioid use disorder, Academic Nursing Pledges Enhanced Education for Advanced Practice Registered Nurses."},{"key":"10.1016\/j.dadr.2022.100111_bib0002","unstructured":"American Association of Colleges of Nursing, 2018. Academic nursing responds to the opioid epidemic. https:\/\/www.aacnnursing.org\/Policy-Advocacy\/Opioids. (Accessed 10\/12\/2022."},{"key":"10.1016\/j.dadr.2022.100111_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108405","article-title":"Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program","volume":"218","author":"Castillo-Carniglia","year":"2021","journal-title":"Drug Alcohol. Depend."},{"key":"10.1016\/j.dadr.2022.100111_bib0004","unstructured":"Centers for Disease Control and Prevention, 2020. Wide-ranging online data for epidemiologic research (WONDER). http:\/\/wonder.cdc.gov. (Accessed 5\/14\/2022."},{"issue":"1","key":"10.1016\/j.dadr.2022.100111_bib0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/pm\/pnz005","article-title":"Differences in Opioid Prescribing Among Generalist Physicians, Nurse Practitioners, and Physician Assistants","volume":"21","author":"Ellenbogen","year":"2020","journal-title":"Pain Med."},{"issue":"6","key":"10.1016\/j.dadr.2022.100111_bib0006","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.amepre.2019.07.026","article-title":"Predicting Opioid Overdose Deaths Using Prescription Drug Monitoring Program Data","volume":"57","author":"Ferris","year":"2019","journal-title":"Am. J. Prev. Med."},{"issue":"34","key":"10.1016\/j.dadr.2022.100111_bib0007","doi-asserted-by":"crossref","first-page":"737","DOI":"10.15585\/mmwr.mm6834a2","article-title":"Changes in Opioid-Involved Overdose Deaths by Opioid Type and Presence of Benzodiazepines, Cocaine, and Methamphetamine - 25 States, July-December 2017 to January-June 2018","volume":"68","author":"Gladden","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.dadr.2022.100111_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108501","article-title":"Implications of county-level variation in U.S. opioid distribution","volume":"219","author":"Griffith","year":"2021","journal-title":"Drug Alcohol. Depend."},{"issue":"9","key":"10.1016\/j.dadr.2022.100111_bib0009","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1007\/s11606-020-05823-0","article-title":"Opioid Prescribing by Primary Care Providers: a Cross-Sectional Analysis of Nurse Practitioner, Physician Assistant, and Physician Prescribing Patterns","volume":"35","author":"Lozada","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.dadr.2022.100111_bib0010","unstructured":"Maryland Department of Health, 2016. Maryland advisory board on prescription drug monitoring (PDMP) minutes: March 7, 2016."},{"key":"10.1016\/j.dadr.2022.100111_bib0011","unstructured":"Maryland Department of Health, 2019. Maryland advisory board on prescription drug monitoring (PDMP) minutes: November 21, 2019."},{"key":"10.1016\/j.dadr.2022.100111_bib0012","unstructured":"Maryland Department of Health, 2020. Maryland PDMP Technical Advisory Committee Meeting Minutes: July 27, 2020."},{"key":"10.1016\/j.dadr.2022.100111_bib0013","unstructured":"Maryland Department of Health, 2022. Maryland advisory board on prescription drug monitoring (PDMP) minutes: February 16, 2022."},{"key":"10.1016\/j.dadr.2022.100111_bib0014","unstructured":"Maryland Division of State Documents, 2021. Code of Maryland Regulations, Department of Health and Mental Hygiene:Chapter 10.27.07.03. Nurse Practitioner-Scope and Standards of Practice Retrieved from https:\/\/www.dsd.state.md.us\/COMAR\/subtitle_chapters\/10_Chapters.aspx. (Accessed 4\/11\/2022."},{"issue":"34","key":"10.1016\/j.dadr.2022.100111_bib0015","doi-asserted-by":"crossref","first-page":"945","DOI":"10.15585\/mmwr.mm6734a2","article-title":"Opportunities to Prevent Overdose Deaths Involving Prescription and Illicit Opioids, 11 States, July 2016-June 2017","volume":"67","author":"Mattson","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"5","key":"10.1016\/j.dadr.2022.100111_bib0016","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/pm\/pny095","article-title":"An Experimental Test of the Effectiveness of Unsolicited Reporting by a Prescription Drug Monitoring Program in Reducing Inappropriate Acquisition of Opioids","volume":"20","author":"McDonald","year":"2019","journal-title":"Pain Med."},{"issue":"6","key":"10.1016\/j.dadr.2022.100111_bib0017","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MLR.0000000000001126","article-title":"Opioid-prescribing Outcomes of Medicare Beneficiaries Managed by Nurse Practitioners and Physicians","volume":"57","author":"Muench","year":"2019","journal-title":"Med. Care"},{"key":"10.1016\/j.dadr.2022.100111_bib0018","unstructured":"OOCC, 2021. Maryland Opioid Operational Command Center (OOCC): 2020 Anuual Report. https:\/\/beforeitstoolate.maryland.gov\/resources-2\/. (Accessed 10\/25\/2021."},{"key":"10.1016\/j.dadr.2022.100111_bib0019","unstructured":"PDMP Center of Excellence at Brandeis University, 2014. Guidance on PDMP best practices: Options for unsolicited reporting."},{"issue":"1","key":"10.1016\/j.dadr.2022.100111_bib0020","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1186\/s12913-019-4642-8","article-title":"The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review","volume":"19","author":"Rhodes","year":"2019","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.dadr.2022.100111_bib0021","unstructured":"The American Medical Association, 2021. Teaching resident physicians about safe opioid prescribing. https:\/\/www.ama-assn.org\/education\/improve-gme\/teaching-resident-physicians-about-safe-opioid-prescribing. (Accessed 4\/29\/2022."},{"key":"10.1016\/j.dadr.2022.100111_bib0022","unstructured":"The Maryland Department of Health, 2020. The 2020 Maryland PDMP Annual Report health.maryland.gov\/pdmp\/Documents\/2020 Annual Report.pdf. (Accessed 4\/29\/2022."},{"issue":"9","key":"10.1016\/j.dadr.2022.100111_bib0023","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/pds.3666","article-title":"Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts","volume":"23","author":"Thomas","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.dadr.2022.100111_bib0024","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jhealeco.2018.01.001","article-title":"Nurse practitioner independence, health care utilization, and health outcomes","volume":"58","author":"Traczynski","year":"2018","journal-title":"J. Health Econ."},{"key":"10.1016\/j.dadr.2022.100111_bib0025","unstructured":"U.S. Bureau of Labor Statistics, 2021. May 2020 State Occupational Employment and Wage Estimates: Maryland. https:\/\/www.bls.gov\/oes\/current\/oes_md.htm#. (Accessed 3\/16\/2022."},{"issue":"11","key":"10.1016\/j.dadr.2022.100111_bib0026","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"1","key":"10.1016\/j.dadr.2022.100111_bib0027","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.outlook.2015.08.005","article-title":"Impact of state nurse practitioner scope-of-practice regulation on health care delivery: Systematic review","volume":"64","author":"Xue","year":"2016","journal-title":"Nursing Outlook"},{"issue":"7","key":"10.1016\/j.dadr.2022.100111_bib0028","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/pm\/pnx044","article-title":"Unsolicited Reporting to Prescribers of Opioid Analgesics by a State Prescription Drug Monitoring Program: An Observational Study with Matched Comparison Group","volume":"19","author":"Young","year":"2018","journal-title":"Pain Med."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724622000865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724622000865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:32:59Z","timestamp":1757421179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724622000865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":28,"alternative-id":["S2772724622000865"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2022.100111","relation":{},"ISSN":["2772-7246"],"issn-type":[{"type":"print","value":"2772-7246"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unsolicited reporting notifications (URNs) through Maryland's prescription drug monitoring program (PDMP): Characteristics of providers","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2022.100111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100111"}}